Formulations of lipid NANO emulsions with controlled pharmacokinetic profiles and methods of making and using the same
A stable emulsion formulation of tricaprilin with Phospholipon® 90G and Kolliphor® RH40, along with a buffer, addresses stability issues in MCTs, ensuring long-term effectiveness as pharmaceutical carriers.
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- CERECIN AUSTRALIA PTY LTD
- Filing Date
- 2024-11-26
- Publication Date
- 2026-07-09
AI Technical Summary
Existing formulations of medium chain triglycerides (MCTs) face stability issues over extended periods, particularly when exposed to varying temperatures, which affects their efficacy as pharmaceutical carriers and active ingredients.
A stable emulsion formulation comprising tricaprilin, emulsifiers such as Phospholipon® 90G and Kolliphor® RH40, a buffer at pH 6.0-7.5, and optional sweeteners and flavors, stabilized through high shear mixing and high-pressure homogenization, ensuring long-term stability and effective delivery.
The emulsion maintains stability for at least 3 months to 12 months at various temperatures, providing a reliable carrier for pharmaceuticals and enhancing the effectiveness of MCTs as active ingredients.
Smart Images

Figure 00000000_0000_ABST